Ghrelin, IGF-I and IGFBP-3 Levels in Children with Type 1 Diabetes Mellitus

Artikel in diesem Heft

1. TABLE OF CONTENTS
2. Different Outcomes of Neonatal Thyroid Function after Graves' Disease in Pregnancy: Patient Reports and Literature Review
3. Analysis of Costimulatory Molecules OX40/4-1BB (CD134/CD137) Detection on Chosen Mononuclear Cells in Children and Adolescents with Graves' Disease During Methimazole Therapy
4. Global Fibrinolytic Capacity is Decreased in Girls with Premature Adrenarche: A New Pathological Finding?
5. Diagnosis of 5α-Reductase Type 2 Deficiency: Contribution of Anti-Müllerian Hormone Evaluation
6. Clinical Picture, Evolution and Peculiar Molecular Findings in a Very Large Pedigree with Wolfram Syndrome
7. BMI-Conditional Standard of Leptin Serum Values in Children: Proposal of a Statistical Procedure for the Analysis of Influencing Variables
8. Serum α-Tocopherol Concentrations and Risk of Type 1 Diabetes Mellitus: A Cohort Study in Siblings of Affected Children
9. Anti-CD38 Autoimmunity in Children with Newly Diagnosed Type 1 Diabetes Mellitus
10. The Role of Diabetes Duration, Pubertal Development and Metabolic Control in Growth in Children with Type 1 Diabetes Mellitus
11. Ghrelin, IGF-I and IGFBP-3 Levels in Children with Type 1 Diabetes Mellitus
12. Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI): Long-term Outcome Following 95% Pancreatectomy
13. Elevated Percentage of L-Selectin on Peripheral Blood Τ Lymphocytes (PBTLs) in Children and Adolescents with Type 1 Diabetes Mellitus and Vascular Complications
14. CALENDAR. INDEX